Bilcare Ltd
BIBilcare Ltd
BI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -3.24 | 0.20 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.09 | 6.40 | 0.53% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Bilcare Limited offers pharmaceutical packaging solutions that are used in pharmaceutical products. It’s other packaging films solutions cater to various industries like ID card industry, specialty films applications and food packaging.
Peers
Compare with peersDivi's Laboratories Ltd
Syngene International Ltd
Aarti Pharmalabs Ltd
Dishman Carbogen Amcis Ltd
Vimta Labs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,914.81 | 2,741.79 | 3,079.16 | 3,057.25 | 2,082.32 | 672.50 | 891.80 | 1,301.65 | 769.70 | 791.12 | ||||||||||
Raw Materials | 1,426.45 | 1,380.80 | 1,577.38 | 1,631.68 | 797.66 | 416.44 | 607.37 | 730.32 | 520.36 | 745.24 | ||||||||||
| Power & Fuel Cost | 122.15 | 118.24 | 118.81 | 119.84 | 73.64 | 29.80 | 34.35 | 42.84 | 39.64 | |||||||||||
| Employee Cost | 510.49 | 524.42 | 558.54 | 616.93 | 370.78 | 55.30 | 59.27 | 71.26 | 71.87 | |||||||||||
| Selling & Administrative Expenses | 268.45 | 142.51 | 136.43 | 163.51 | 104.35 | 20.46 | 28.01 | 31.87 | 25.46 | |||||||||||
| Operating & Other expenses | 467.37 | 278.58 | 229.97 | 296.61 | 436.59 | 54.37 | 58.84 | 131.46 | 57.34 | |||||||||||
EBITDA | 119.90 | 297.24 | 458.03 | 228.68 | 299.30 | 96.13 | 103.96 | 293.90 | 55.03 | 45.88 | ||||||||||
| Depreciation/Amortization | 163.60 | 176.95 | 416.19 | 378.36 | 238.80 | 45.51 | 39.25 | 37.81 | 44.95 | 46.53 | ||||||||||
| PBIT | -43.70 | 120.29 | 41.84 | -149.68 | 60.50 | 50.62 | 64.71 | 256.09 | 10.08 | -0.65 | ||||||||||
| Interest & Other Items | 150.76 | 176.35 | 249.06 | 282.84 | 174.16 | 75.59 | 68.93 | 60.00 | 81.79 | 87.66 | ||||||||||
| PBT | -194.46 | -56.06 | -207.22 | -432.52 | -113.66 | -24.97 | -4.22 | 196.09 | -71.71 | -88.31 | ||||||||||
| Taxes & Other Items | -109.61 | 28.47 | -6.07 | 22.58 | -10.11 | -3.88 | 8.37 | 181.04 | -38.47 | -48.15 | ||||||||||
| Net Income | -84.85 | -84.53 | -201.15 | -455.10 | -103.55 | -21.09 | -12.59 | 15.05 | -33.24 | -40.16 | ||||||||||
| EPS | -36.04 | -35.90 | -85.43 | -193.29 | -43.98 | -8.96 | -5.35 | 6.39 | -14.12 | -17.06 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bilcare Ltd | -3.91 | 0.20 | — |
| Divi's Laboratories Ltd | 99.52 | 11.73 | 0.50% |
| Syngene International Ltd | 68.38 | 8.19 | 0.14% |
| Aarti Pharmalabs Ltd | 27.30 | 3.37 | 0.46% |
Price Comparison
Compare BI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
BI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2012
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2012
Cash Dividend
Ex DateEx DateSep 20, 2011
Dividend/Share
₹3.00
Ex DateEx Date
Sep 20, 2011
Net Loss of Bilcare reported to Rs 16.03 crore in the quarter ended September 2024 as against net loss of Rs 7.59 crore during the previous quarter ended September 2023. Sales rose 6.22% to Rs 201.74 crore in the quarter ended September 2024 as against Rs 189.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales201.74189.92 6 OPM %3.798.79 - PBDT-12.127.15 PL PBT-23.16-3.33 -595 NP-16.03-7.59 -111 Powered by Capital Market - Live
Bilcare will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Bilcare announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net profit of Bilcare declined 89.57% to Rs 1.40 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. Sales rose 33.06% to Rs 4.87 crore in the quarter ended June 2024 as against Rs 3.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.873.66 33 OPM %-17.45-39.62 - PBDT2.36-0.99 LP PBT1.63-1.43 LP NP1.4013.42 -90 Powered by Capital Market - Live
Net Loss of Bilcare reported to Rs 6.39 crore in the quarter ended June 2024 as against net loss of Rs 7.91 crore during the previous quarter ended June 2023. Sales rose 6.52% to Rs 194.14 crore in the quarter ended June 2024 as against Rs 182.25 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales194.14182.25 7 OPM %9.767.39 - PBDT1.83-1.95 LP PBT-9.69-12.45 22 NP-6.39-7.91 19 Powered by Capital Market - Live
Bilcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -24.11%, vs industry avg of 4.51%
Decreasing Market Share
Over the last 5 years, market share decreased from 24.93% to 4.37%